跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 494 条关于
“VP1”
全部
494
临床试验
284
药物
157
机构
2
资讯
51
去年
Vaxart's Oral Norovirus Vaccine Shows Promising Immune Response in Elderly Phase 1b Trial
去年
Lexeo Therapeutics to Showcase Advanced AAV Manufacturing Platform at ASGCT Annual Meeting
去年
Norovirus Vaccine Development Advances with mRNA and Oral Tablet Candidates
去年
Replimune's RP1 Receives FDA Breakthrough Therapy Designation for Advanced Melanoma
2年前
RP1/Nivolumab Combination Shows Durable Responses in Advanced Melanoma
去年
Replimune's RP1 Receives FDA Breakthrough Therapy Designation and BLA Submission for Advanced Melanoma
去年
FDA Reviewing RP1 and Nivolumab Combination for Advanced Melanoma After PD-1 Inhibitor Failure
2年前
Replimune's RP1 Receives Positive FDA Feedback for Melanoma Treatment
去年
Replimune's RP1 Receives FDA Breakthrough Therapy Designation for Advanced Melanoma
去年
Replimune Submits BLA for RP1 Melanoma Treatment, Gains FDA Breakthrough Therapy Designation
第 1 页,共 6 页
上一页
下一页